| MicroRNA 122, regulated by GRLH2, protects livers of mice and patients from ethanol-induced liver disease A Satishchandran, A Ambade, S Rao, YC Hsueh, A Iracheta-Vellve, ... Gastroenterology 154 (1), 238-252. e7, 2018 | 139 | 2018 |
| Biomarkers of macrophage activation and immune danger signals predict clinical outcomes in alcoholic hepatitis B Saha, D Tornai, K Kodys, A Adejumo, P Lowe, C McClain, M Mitchell, ... Hepatology 70 (4), 1134-1149, 2019 | 64 | 2019 |
| IL‐1 receptor antagonist plus pentoxifylline and zinc for severe alcohol‐associated hepatitis G Szabo, M Mitchell, CJ McClain, S Dasarathy, B Barton, AJ McCullough, ... Hepatology 76 (4), 1058-1068, 2022 | 52 | 2022 |
| Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitis T Tornai, E Palyu, Z Vitalis, I Tornai, D Tornai, P Antal-Szalmas, ... World journal of gastroenterology 23 (29), 5412, 2017 | 48 | 2017 |
| Neutrophil extracellular traps contribute to liver damage and increase defective low-density neutrophils in alcohol-associated hepatitis Y Cho, TN Bukong, D Tornai, M Babuta, IS Vlachos, E Kanata, D Catalano, ... Journal of Hepatology 78 (1), 28-44, 2023 | 42 | 2023 |
| Deleterious effect of proton pump inhibitors on the disease course of cirrhosis T Janka, T Tornai, B Borbély, D Tornai, I Altorjay, M Papp, Z Vitális European journal of gastroenterology & hepatology 32 (2), 257-264, 2020 | 35 | 2020 |
| Presepsin teardown-pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis M Papp, T Tornai, Z Vitalis, I Tornai, D Tornai, T Dinya, A Sumegi, ... World Journal of Gastroenterology 22 (41), 9172, 2016 | 30 | 2016 |
| Macrophage activation marker, soluble CD 163, is an independent predictor of short‐term mortality in patients with cirrhosis and bacterial infection T Tornai, Z Vitalis, N Sipeki, T Dinya, D Tornai, P Antal‐Szalmas, ... Liver International 36 (11), 1628-1638, 2016 | 30 | 2016 |
| Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis T Tornai, D Tornai, N Sipeki, I Tornai, R Alsulaimani, K Fechner, ... Scientific reports 8 (1), 399, 2018 | 28 | 2018 |
| Lectin‐complement pathway molecules are decreased in patients with cirrhosis and constitute the risk of bacterial infections I Foldi, T Tornai, D Tornai, N Sipeki, Z Vitalis, I Tornai, T Dinya, ... Liver International 37 (7), 1023-1031, 2017 | 26 | 2017 |
| Inhibition of triggering receptor expressed on myeloid cells 1 ameliorates inflammation and macrophage and neutrophil activation in alcoholic liver disease in mice D Tornai, I Furi, ZT Shen, AB Sigalov, S Coban, G Szabo Hepatology Communications 3 (1), 99-115, 2019 | 23 | 2019 |
| Emerging medical therapies for severe alcoholic hepatitis D Tornai, G Szabo Clinical and Molecular Hepatology 26 (4), 686, 2020 | 21 | 2020 |
| Phenotypic polymorphism of haptoglobin: a novel risk factor for the development of infection in liver cirrhosis Z Vitalis, I Altorjay, I Tornai, K Palatka, S Kacska, E Palyu, D Tornai, ... Human immunology 72 (4), 348-354, 2011 | 19 | 2011 |
| Inhibition of the inflammasome signaling cascade reduces alcohol consumption in female but not male mice PP Lowe, Y Cho, D Tornai, S Coban, D Catalano, G Szabo Alcoholism: Clinical and Experimental Research 44 (2), 567-578, 2020 | 17 | 2020 |
| Serological biomarkers for management of primary sclerosing cholangitis D Tornai, PL Ven, PL Lakatos, M Papp World Journal of Gastroenterology 28 (21), 2291-2301, 2022 | 12 | 2022 |
| Autoantibodies testing in autoimmunity: diagnostic, prognostic and classification value S Sciascia, N Bizzaro, PL Meroni, B Dimitrios, MO Borghi, X Bossuyt, ... Autoimmunity Reviews 22 (7), 103356, 2023 | 11 | 2023 |
| Functional polymorphisms of innate immunity receptors are not risk factors for the non‐SBP type bacterial infections in cirrhosis T Dinya, T Tornai, Z Vitalis, I Tornai, B Balogh, D Tornai, P Antal‐Szalmas, ... Liver International 38 (7), 1242-1252, 2018 | 11 | 2018 |
| Abnormal ferritin levels predict development of poor outcomes in cirrhotic outpatients: a cohort study D Tornai, P Antal-Szalmas, T Tornai, M Papp, I Tornai, N Sipeki, T Janka, ... BMC Gastroenterology 21 (1), 2021 | 9 | 2021 |
| Increased sTREM-1 levels identify cirrhotic patients with bacterial infection and predict their 90-day mortality D Tornai, Z Vitalis, A Jonas, T Janka, I Foldi, T Tornai, N Sipeki, A Csillag, ... Clinics and Research in Hepatology and Gastroenterology 45 (5), 101579, 2021 | 8 | 2021 |
| serologic antibodies in primary sclerosing cholangitis – a tell‐tale sign of compromised gut‐liver immunity? D Tornai, M Papp Alimentary Pharmacology & Therapeutics 53 (2), 350-351, 2020 | 6 | 2020 |
Maria PappUniversity of Debrecen在 med.unideb.hu 的电子邮件经过验证
